Enterprise-wide Business Synergy and Profit Through Quality Metrics
Creating a Competitive Edge Through Quality Metrics
Creating a Competitive Edge Through Quality Metrics
Since the advent of the CGMPS in 1978, FDA-regulated companies responsible for the manufacture, preparation, distribution, or processing of human drugs, have utilized some degree of quality metrics for decision-making; moreover, recent manufacturing innovations coupled with advances in the lifecycle of the drug development and approval process unconditionally warrant the use of quality metrics to monitor quality control at critical milestones.
Download this white paper to discover: